Literature DB >> 33411809

Altered acylated ghrelin response to food intake in congenital generalized lipodystrophy.

Camilla O D Araújo1, Renan M Montenegro2, Amanda P Pedroso1, Virgínia O Fernandes2, Ana Paula D R Montenegro2, Annelise B de Carvalho2, Lila M Oyama1, Carla S C Maia3, Eliane B Ribeiro1.   

Abstract

BACKGROUND: Patients with congenital generalized lipodystrophy (CGL) have very low levels of leptin and are described as having a voracious appetite. However, a direct comparison between CGL and eutrophic individuals is lacking, regarding both appetite parameters and acylated ghrelin, the hormone form that is active in acute food intake stimulation. The objective of the present study was to address whether and in what extent the subjective appetite parameters and acylated ghrelin response to a meal are affected in CGL individuals, in comparison to eutrophic individuals. Additionally, an obese group was included in the study, to allow the comparison between a leptin-resistant and a leptin-deficient condition on these aspects.
METHODS: Eutrophic controls (EUT, n = 10), obese subjects (OB, n = 10) and CGL (n = 11) were fasted overnight and then received an ad libitum meal. Blood was collected and the visual analogue scale was applied before and 90 minutes after the meal. An additional blood sample was collected at 60 minutes for ghrelin determination.
RESULTS: The CGL patients showed low fasting levels of leptin and adiponectin, dyslipidemia, and insulin resistance. The caloric intake was similar among the 3 groups. However, both CGL (p = 0.02) and OB (p = 0.04) had shorter satiation times than EUT. The CGL patients also had lower satiety time (p = 0.01) and their sensation of hunger was less attenuated by the meal (p = 0.03). Fasting acylated ghrelin levels were lower in CGL than in EUT (p = 0.003). After the meal, the levels tended to decrease in EUT but not in CGL and OB individuals.
CONCLUSION: The data indicate that, although not hyperphagic, the CGL patients present appetite disturbances in relation to eutrophic individuals. Their low fasting levels of acylated ghrelin and the absence of the physiological drop after meal intake suggest a role of these disturbances in hunger attenuation and satiety but not in acute satiation.

Entities:  

Year:  2021        PMID: 33411809      PMCID: PMC7790291          DOI: 10.1371/journal.pone.0244667

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  64 in total

1.  Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study.

Authors:  Gulcin Akinci; Haluk Topaloglu; Tevfik Demir; Ayca Ersen Danyeli; Beril Talim; Fatma Ela Keskin; Pinar Kadioglu; Enez Talip; Canan Altay; Guzin Fidan Yaylali; Habib Bilen; Banu Nur; Leyla Demir; Huseyin Onay; Baris Akinci
Journal:  Neuromuscul Disord       Date:  2017-06-01       Impact factor: 4.296

Review 2.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 3.  Congenital lipodystrophies and dyslipidemias.

Authors:  Xavier Prieur; Cedric Le May; Jocelyne Magré; Bertrand Cariou
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

4.  Determining residual adipose tissue characteristics with MRI in patients with various subtypes of lipodystrophy.

Authors:  Canan Altay; Mustafa Seçil; Tevfik Demir; Tahir Atik; Gülçin Akıncı; Nilüfer Özdemir Kutbay; Ela Keskin Temeloğlu; Ilgın Yıldırım Şimşir; Seçil Özışık; Leyla Demir; Erdal Eren; Emine Burçin Tuna; Hasibe Aytaç; Hüseyin Onay; Barış Akıncı
Journal:  Diagn Interv Radiol       Date:  2017 Nov-Dec       Impact factor: 2.630

5.  Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.

Authors:  Talia Diker-Cohen; Elaine Cochran; Phillip Gorden; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2015-03-03       Impact factor: 5.958

6.  Aggressive papillary thyroid carcinoma in a child with type 2 congenital generalized lipodystrophy.

Authors:  Grayce Ellen da Cruz Paiva Lima; Virgínia Oliveira Fernandes; Ana Paula Dias Rangel Montenegro; Annelise Barreto de Carvalho; Lia Beatriz de Azevedo Sousa Karbage; Lindenberg Barbosa Aguiar; Mário Sérgio Rocha Macedo; Luis Alberto Albano Ferreira; Renan Magalhães Montenegro Júnior
Journal:  Arch Endocrinol Metab       Date:  2019-02       Impact factor: 2.309

7.  Genetic ablation of caveolin-1 confers protection against atherosclerosis.

Authors:  Philippe G Frank; Hyangkyu Lee; David S Park; Narendra N Tandon; Phillip E Scherer; Michael P Lisanti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-16       Impact factor: 8.311

8.  Pseudoacromegaly in congenital generalised lipodystrophy (Berardinelli-Seip syndrome).

Authors:  Partha Pratim Chakraborty; Saumik Datta; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  BMJ Case Rep       Date:  2016-04-11

9.  Autonomic modulation in patients with congenital generalized lipodystrophy (Berardinelli-Seip syndrome).

Authors:  Carlos A Faria; Ruy S Moraes; Dário C Sobral-Filho; Antônio G Rego; Maria F P Baracho; Eryvaldo S T Egito; José Brandão-Neto
Journal:  Europace       Date:  2009-04-17       Impact factor: 5.214

Review 10.  Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease.

Authors:  Iram Hussain; Nivedita Patni; Abhimanyu Garg
Journal:  Pathology       Date:  2018-12-27       Impact factor: 5.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.